Life Stem Genetics Inc.

OTC: LIFS · Healthcare · Biotechnology

PublicHQ East Stroudsburg, NVCIK 0001556377Reports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ 10GM —SS 34

v0.1 · 25/100 weight · pillars only

↑ Altman-Z, listing tenure · ↓ disclosure history, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$39.1k

Employees

—

Market cap

$4.6k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02013

Net income-$39.1k-$39.1k2013

Total assets$388$3882013

Liabilities$21.9k$21.9k2013

Equity-$21.5k-$21.5k2013

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Life Stem Genetics Inc. booked $0 in FY2013 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Choom Holdings Inc.——Innovation1 Biotech Inc.——Ingen Technologies, Inc.——Orthometrix, Inc.——

Key facts

CEOGloria Simov

SectorHealthcare

IndustryBiotechnology

HeadquartersEast Stroudsburg, NV

ExchangeOTC: LIFS

Employees—

IPO date2013-10-22

Latest filings

8-K2014-07-23 10-Q2014-05-08 8-K2014-03-17 10-Q2014-02-14 8-K2013-12-10 8-K2013-12-10 10-Q2013-11-19 8-K2013-11-13

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.